An open trial of naltrexone for opiate dependence

Drug and Alcohol Review

Volumn 17, Issue 2, 1998, Pages 167-174

  Foy, Aidan ^a   Sadler, Craig ^a   Taylor, Andrew ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Naltrexone; Opiate dependence

Indexed keywords

EID: 0032388514     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595239800186971     Document Type: Article

References (23)

1. Archer S. Historical perspective on the chemistry and development of naltrexone. In: Willette RE, Barnett G, eds. Narcotic antagonists: naltrexone pharmacochemistry and sustained release preparations, NIDA Research Monograph 28. Washington, DC: US Department of Health and Human Services, 1981: 132-46.
2. Verebey K. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics. In: Willette RE, Barnett G, eds. Narcotic antagonists: naltrexone pharmacochemistry and sustained release preparations, NIDA Research Monograph 28. Washington, DC:US Department of Health and Human Services, 1981: 147-58.
3. Resnick RB, Volavka J, Freedman AM, et al. Studies of EN - 1639A (naltrexone): a new narcotic antagonist. Am J Psychiat 1974;131:646-50.
4. Judson BA, Carney TM, Goldstein A. Naltrexone treatment of heroin addiction: efficacy and safety in a double blind dosage comparison. Drug Alcohol Depend 1981;7:325-46.
5. Bradford A, Hurley F, Golondzowski O, Dorrier C. Interim report on clinic intake and safety data collected from 17 NIDA funded naltrexone studies. NIDA Res Monogr 1976;9:163-71.
6. Pfohol DN, Allen JL, Atkinson RL, Knopman DS, Malcolm RJ, Mitchell JE, Morley JE. Naltrexone hydrochloride (Trexan) a review of serum transaminase elevations at high dosage. NIDA Res Monogr 1986;67:66-72.
7. Crowley TJ, Wagner JE, Zerbe G, Macdonald M. Naltrexone induced dysphoria in former opioid addicts. Am J Psychiat 1985;142:1081-4.
8. Fram Dlt, Marino J, Holden R. Naltrexone treatment - the problem of patient acceptance. J Subst Abuse Treat 1989;6:199-22.
9. Miotto K, McCann MJ, Rawson RA, Frosch D, Ling W. Overdose suicide attempts and death among a cohort of naltrexone 0 treated opioid addicts. Drug Alcohol Depend 1997;45:131-4.
10. National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Clinical evaluation of naltrexone treatment of opiate dependent individuals. Arch Gen Psychiat 1978;35:335-40.
11. Roth A, Hogan I, Farren C. Naltrexone plus group therapy for the treatment of opiate abusing health-care professionals. J Subst Abuse Treat 1997;14:19-22.
12. Capone T, Brahen L, Condren R, Kordal N, Melchionda R, Peterson M. Retention and outcome in a narcotic antagonist treatment program. J Clin Psychol 1986;42:825-33.
13. Osborn E, Grey C, Reznikoff M. Psychosocial adjustment modality choice and outcome in naltrexone versus methadone treatment. Am J Drug Alcohol Abuse 1986;12:383-8.
14. Ochoa E, Arias F, Somoza JC, Lopez-Ibor JJ. Treatment with naltrexone in opiate dependents: 2 years follow up. Arch Neurobiol (Madrid) 1992;55:224-7.
15. Schifano F, Marra R. Naltrexone for heroin addiction: encouraging results from Italy. Int J Clin Pharmacol Ther Toxicol 1990;28:144-6.
16. Gonzalez JP, Brogden RN. Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988;35:192-213.
17. Lopez-Ibor AJJ, Perez delos Cobos JC, Ochoa E, Hernandes-Herreros M., Maintenance treatment for opiate dependence at a naltrexone clinic. Actas Luso Esp Neurol Psiquatr Cienc Afines 1990;18:296-305.
18. Garcia-Alonso F, Gutierrez M, San L, et al. A multicentre study to introduce naltrexone for opiate dependence in Spain. Drug Alcohol Depend 1989;23:117-21.
19. San L, Pomarol G, Peri JM, Olle JM, Cami J. Follow up after a six month maintenance period on naltrexone versus placebo in heroin addicts. Br J Addic 1991;86:983-90.
20. Lerner A, Sigal M, Bacala A, Shiff R, Burganski I, Gelkopf M. A naltrexone double blind placebo controlled study in Israel. Isr J Psychiat Relat Sci 1992;29:36-43.
21. Ross R, Horwitz CA, Hager H, et al. Preliminary evaluation of a latex agglutination-inhibition tube test for morphine. Clin Chem 1975;21:139-43.
22. Adler FL, Liu CT. Detection of morphine by haemagglutination-inhibition. J Immunol 1971; 106:1684-5.
23. Mattick RP, Hall W, eds. A treatment outline for approaches to opioid dependence. National Drug Strategy Monograph Series No. 21. Canberra: Aust Government Publishing Service, 1993.